Just reported
From The Cigna's results release of November 5, 2026; its quarterly report has since been filed.
Actual
$73.68B
+5.6% y/y
+2.8% q/q
Guided
—
No guide given
Actual
$5.47
-22% y/y
-13% q/q
Guided
—
No guide given
Actual
$2.4B
-7.1% y/y
-10% q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Shares of revenue are estimates for three months ended June 30, 2026, not figures from a filing.
Express Scripts pharmacy benefit services
Manages prescription claims and pharmacy networks for client health plans, helps clients choose which drugs their plans cover, and negotiates drug discounts and rebates.
Accredo Specialty Pharmacy
Dispenses medicines for complex or rare conditions and provides patients with support from pharmacists, clinicians and in-home nursing services.
CuraScript SD
Supplies specialty medicines and medical products directly to hospitals, clinics and other health care providers.
Cigna employer health plans
Medical insurance and plan-administration services for employers, with options for employers that pay their employees' medical claims themselves.
International Health coverage
Health and related insurance for multinational employers, people working across borders, and employers and individuals in selected countries.
MD Live and EviCore care services
MD Live provides virtual medical and behavioral health visits; EviCore helps health plans manage coverage and care for certain medical services.
Cigna processes prescription claims and manages pharmacy networks and drug coverage for clients. It also runs home-delivery and specialty pharmacies, supplies specialty medicines to clinics and hospitals, and provides virtual care and medical care-management services. Its insurance business sells health coverage and administers employer health plans, including plans where the employer pays medical claims itself.
Built from The Cigna Group’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
$301.43-0.6%Nov 11 close
Figures through September 30, 2026, from the 10-Q filed November 5, 2026
Cigna sells prescription-drug benefits and pharmacy services to employers, health plans and government programs, plus medical insurance to employers and individuals.
The themes The Cigna is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Grade A
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 32 quarters of The Cigna Group’s grade history. The other 30 go back to February 2019.